Press Release Archive

January 22, 2019

Johnson & Johnson Reports 2018 Fourth-Quarter Results:
Innovation January 17, 2019

Johnson & Johnson Announces Research Study with Apple Watch to Help Improve AFib Outcomes Including Stroke Prevention
Innovation January 10, 2019

Dr. Paul Janssen Award for Biomedical Research Issues 2019 Call for Nominations to Celebrate Champions of Science
Latest News January 02, 2019

Johnson & Johnson Announces Quarterly Dividend for First Quarter 2019
Our Company December 24, 2018

Johnson & Johnson to Participate in 37^th Annual JP Morgan Health Care Conference
Latest News December 19, 2018

Johnson & Johnson to Host
Investor Conference Call on Fourth-Quarter Results
Our Company December 17, 2018

Johnson & Johnson Announces $5 Billion Share Repurchase Program
Our Company December 14, 2018

Statement on Reuters Talc Article
Innovation December 14, 2018

Janssen Submits Supplemental New Drug Application (sNDA) to FDA for XARELTO^® (rivaroxaban) to Prevent Venous Thromboembolism (VTE) in Acute Medically Ill Patients
Innovation December 13, 2018

Janssen Signs Results-Based Contract with Oklahoma Health Care Authority (OHCA) for its Long-Acting Injectable Schizophrenia Medicines

See More Press Releases